<unk>  are coordination complexes of<unk>  complexes that have<unk><unk>  properties. They promise to provide alternatives to platinum-based drugs for<unk><unk>  therapy. No<unk> has been commercialized. Since 1979, when Cisplatin entered clinical trials, there has been continuing interest in alternative metal-based drugs. The leading<unk> -based candidates are BOLD-100 and TLD-1433. Other<unk>  based therapeutics that have been tested clinically include NAMI-A and KP1019. The first<unk> -based drug to enter clinical trials was NAMI-A. More<unk>  drugs are still under development.<unk>  complexes as<unk><unk>  drugs have been traditionally designed to mimic platinum drugs for targeting DNA, but other approaches also exist.
Ruthenium anti-cancer drugs
Perfluorinated compound
SENSOR-Pesticides
Topological drugs
Concierge medicine
Covid-Organics
Byzantine medicine
Animal products in pharmaceuticals